Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Collplant Holdings ( (CLGN) ) has provided an update.
On May 30, 2025, CollPlant Biotechnologies announced a $3.6 million registered direct offering, issuing 1,200,002 ordinary shares at $3.00 per share. The offering, expected to close by June 2, 2025, aims to bolster the company’s financial flexibility and support its business plan, including collaborations with AbbVie and ongoing research and development initiatives. This move reflects CollPlant’s strategic efforts to enhance its market position in the regenerative and aesthetic medicine sectors.
The most recent analyst rating on (CLGN) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on Collplant Holdings stock, see the CLGN Stock Forecast page.
Spark’s Take on CLGN Stock
According to Spark, TipRanks’ AI Analyst, CLGN is a Neutral.
Collplant Holdings exhibits significant financial weaknesses, primarily due to a drastic revenue decline and negative cash flow. While technological advancements and strategic collaborations provide some optimism, the current financial instability remains the most significant risk. Technical analysis suggests potential overvaluation, reinforcing a cautious outlook.
To see Spark’s full report on CLGN stock, click here.
More about Collplant Holdings
CollPlant Biotechnologies is a regenerative and aesthetic medicine company focused on developing innovative technologies and products using its proprietary plant-based genetic engineering technology to produce recombinant human collagen (rhCollagen). The company’s products are designed for applications in 3D bioprinting of tissues and organs, tissue repair, and medical aesthetics. CollPlant has a notable partnership with Allergan, an AbbVie company, for the development and commercialization of dermal and soft tissue fillers.
Average Trading Volume: 57,307
Technical Sentiment Signal: Hold
Current Market Cap: $52M
For a thorough assessment of CLGN stock, go to TipRanks’ Stock Analysis page.